Blog

Egypt's Journey Towards WHO ML3 Recognition: Implications and Opportunities

The World Health Organization's Global Benchmarking Tool (GBT) serves as a critical framework for assessing and improving regulatory systems for medicines and vaccines. Achieving a higher maturity level, such as ML3 (Maturity Level 3), reflects a country's ability to oversee, regulate, and ensure the quality, safety, and efficacy of pharmaceuticals. This blog explores Egypt's current position, the significance of attaining ML3, and how RegExperts supports stakeholders throughout this transformative journey.

Opportunities in the Egyptian Cosmetic Industry: A Shift Towards Locally Manufactured Products

The Egyptian cosmetic industry is witnessing a significant transformation as consumers increasingly prefer locally manufactured products over imported ones. This shift stems from economic factors, such as currency fluctuations and import restrictions, and a growing trust in the quality of Egyptian-made cosmetics. This blog explores the opportunities within this market and how RegExperts can assist companies in navigating the regulatory, manufacturing, and quality assurance processes to successfully enter the industry.

Strategic and Regulatory Planning for Toll Manufacturing Startups in Egypt

The Egyptian market is witnessing a surge in toll manufacturing startups, driven by the growing demand for pharmaceuticals, cosmetics, dietary supplements, veterinary, and health products. However, navigating the regulatory and market dynamics can be complex. This blog explores how a combined regulatory and market-driven approach can help these startups develop a strategic plan, choose the right product mix, and balance compliance with cost efficiency to achieve a smooth market entry.